Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

Of late, pharmaceutical behemoth Pfizer Inc.’s PFE stock has struggled, but it remains a bargain with generous dividends. Its ...

We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a ...

We recently published a list of Dividend Contenders List: Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other top dividend contenders.

Reeling off a list of several programmes ... drugs will continue to deliver for Pfizer however, and elsewhere the results were not so impressive. Oncology products fell 2% to $3.1 billion, dragged ...

With the end of the pandemic, sales of Pfizer’s COVID products, Comirnaty and Paxlovid, came down to around $11 billion in 2024 from $56.7 billion in 2022. In 2025, Pfizer’s revenues from ...

Pfizer denied releasing the list and said it did not reflect the ... AFP Fact Check that the most recent safety update to the product information took place in November 2024, to include further ...